New research from Northwestern Medicine and the Rehabilitation Institute of Chicago scientists has identified the brain region responsible for the placebo response to pain.
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
Dimitri Krainc, MD, PhD, Aaron Montgomery Ward Professor and chair of Neurology, has received the Javits Award from the National Institute of Neurological Disorders and Stroke.
Huda Zoghbi, MD, recipient of the inaugural Mechthild Esser Nemmers Prize in Medical Science at Northwestern University, gave a presentation on her research journey studying the neurological disorder Rett syndrome.
The National Institute on Aging has renewed funding for the Cognitive Neurology and Alzheimer’s Disease Center, supporting an additional five years of research, and marking 25 years of continuous grant support.
Top neuroscientists from Feinberg and across Chicago joined U.S. Sen. Mark Kirk to announce plans for a $25 million statewide consortium to advance brain research in Illinois.
A new study, led by scientists at the Rehabilitation Institute of Chicago, helps explain the phenomenon of movement chunking, which has important implications for the treatment and rehabilitation of patients with neurological disorders.
Northwestern Medicine scientists have demonstrated how gene therapy targeted against a set of proteins called HCN channels could lead to new treatments for depression.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.